J. Kanitakis, Les métastases cutanées des cancers profonds, Presse Med, vol.22, pp.631-636, 1993.

R. Schwartz, S. B. Sariya, D. Ruth, K. Adams-mcdonnell, R. Cusack et al., Histopathologic aspects of cutaneous metastatic disease, Journal of the American Academy of Dermatology, vol.33, issue.4, pp.649-657, 1995.
DOI : 10.1016/0190-9622(95)91288-6

P. Chu, E. Wu, and L. Weiss, Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases, Modern Pathology, vol.13, issue.9, pp.962-972, 2000.
DOI : 10.1038/modpathol.3880175

X. Leroy, M. Copin, F. Boman, and B. Gosselin, Cytokeratins 7 and 20: aid in tumor typing, Ann Pathol, vol.18, pp.103-109, 1998.

J. Freund, C. Domon-dell, M. Kedinger, and I. Duluc, The <i>Cdx-1</i> and <i>Cdx-2</i> homeobox genes in the intestine, Biochemistry and Cell Biology, vol.76, issue.6, pp.957-969, 1998.
DOI : 10.1139/bcb-76-6-957

F. Drummond, W. Putt, M. Fox, and Y. Edwards, gene, Annals of Human Genetics, vol.61, issue.5, pp.393-400, 1997.
DOI : 10.1046/j.1469-1809.1997.6150393.x

M. Li and A. Folpe, CDX-2, a New Marker for Adenocarcinoma of Gastrointestinal Origin, Advances in Anatomic Pathology, vol.11, issue.2, pp.101-105, 2004.
DOI : 10.1097/00125480-200403000-00004

R. Werling, H. Yaziji, C. Bacchi, and A. Gown, CDX2, a Highly Sensitive and Specific Marker of Adenocarcinomas of Intestinal Origin, The American Journal of Surgical Pathology, vol.27, issue.3, pp.303-310, 2003.
DOI : 10.1097/00000478-200303000-00003

M. Barbareschi, B. Murer, T. Colby, M. Chilosi, E. Macri et al., CDX-2 Homeobox Gene Expression Is a Reliable Marker of Colorectal Adenocarcinoma Metastases to the Lungs, The American Journal of Surgical Pathology, vol.27, issue.2, pp.141-149, 2003.
DOI : 10.1097/00000478-200302000-00001

V. Kaimaktchiev, L. Teraciano, L. Tornillo, H. Spichtin, D. Stoios et al., The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas, Modern Pathology, vol.176, issue.11, pp.1392-1399, 2004.
DOI : 10.1038/modpathol.3800205

T. Hinoi, T. M. Lucas, P. Caca, K. Dunn, R. Macri et al., Loss of CDX2 Expression and Microsatellite Instability Are Prominent Features of Large Cell Minimally Differentiated Carcinomas of the Colon, The American Journal of Pathology, vol.159, issue.6, pp.2239-2248, 2001.
DOI : 10.1016/S0002-9440(10)63074-X

R. Saad, J. Silverman, M. Khalifa, and C. Rowsell, CDX2, Cytokeratins 7 and 20 Immunoreactivity in Rectal Adenocarcinoma, Applied Immunohistochemistry & Molecular Morphology, vol.17, issue.3, pp.196-201, 2009.
DOI : 10.1097/PAI.0b013e31819268f2

R. Saad, N. Ismii, V. Dubé, S. Nofech-mozes, and M. Khalifa, CDX-2 Expression Is a Common Event in Primary Intestinal-type Endocervical Adenocarcinoma, American Journal of Clinical Pathology, vol.132, issue.4, pp.531-538, 2004.
DOI : 10.1309/AJCP7E5ASGOENPFP

M. Nisi, D. Amuri, A. Toscano, M. Lalinga, A. Pirtoli et al., Usefulness of CDX2 in the diagnosis of extramammary Paget disease associated with malignancies of intestinal type, British Journal of Dermatology, vol.119, issue.3, pp.677-679, 2005.
DOI : 10.1111/j.1365-2133.2005.06798.x

H. Zeng, R. Cartun, A. Ricci, and . Jr, Potential Diagnostic Utility of CDX-2 Immunophenotyping in Extramammary Paget??s Disease, Applied Immunohistochemistry & Molecular Morphology, vol.13, issue.4, pp.342-346, 2005.
DOI : 10.1097/01.pai.0000163989.12896.d2

Y. Baba, K. Nosho, K. Shima, E. Freed, N. Irahara et al., Relationship of CDX2 Loss with Molecular Features and Prognosis in Colorectal Cancer, Clinical Cancer Research, vol.15, issue.14, pp.4665-4673, 2009.
DOI : 10.1158/1078-0432.CCR-09-0401

M. Witek, K. Nielsen, R. Walters, T. Hyslop, J. Palazzo et al., The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas, Clinical Cancer Research, vol.11, issue.24, pp.8549-8556, 2005.
DOI : 10.1158/1078-0432.CCR-05-1624

L. Dang, F. Chen, C. Ying, S. Chun, S. Knock et al., CDX2 has tumorigenic potential in the human colon cancer cell lines LOVO and SW48 22 Mazziotta R, Borczuk A, Powell CA and Mansukhani M: CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall, Oncogene Appl Immmunohistochem Mol Morphol, vol.25, issue.13, pp.2264-2272, 2005.

J. Kanitakis, Mammary and extramammary Paget's disease, Journal of the European Academy of Dermatology and Venereology, vol.33, issue.0, pp.581-590, 2007.
DOI : 10.1111/j.1365-2133.2005.06865.x